Tovanor Breezhaler 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

tovanor breezhaler

novartis europharm limited - glikopironija bromīds - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - tovanor breezhaler ir indicēts kā uzturēšanas bronhodilatatora terapija simptomu mazināšanai pieaugušiem pacientiem ar hronisku obstruktīvu plaušu slimību (hops).

Xiliarx 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - cukura diabēts, 2. tips - cukura diabēts - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).

Bemrist Breezhaler 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

bemrist breezhaler

novartis europharm limited  - indacaterol, mometasone furoate - astma - zāles obstruktīvu elpceļu slimību, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Zimbus Breezhaler 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

zimbus breezhaler

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - zāles obstruktīvu elpceļu slimību, - maintenance treatment of asthma in adults whose disease is not adequately controlled.